Recent changes in Medicare regulations for suppliers of diabetes meters and strips have accelerated the concern of diabetes technology leaders that current testing controls are inadequate to insure blood glucose meter accuracy post market sale. This comes amid the heightened awareness in the Food and Drug Administration (FDA) of the need to strengthen the overall accuracy guidelines for these devices.

Read more